Skip to content

Ultrasound Staging in the Placenta Accreta

Efficacy of Ultrasound Staging System in Prediction of Morbidly Adherent Placenta

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04253197
Enrollment
75
Registered
2020-02-05
Start date
2017-03-14
Completion date
2019-12-25
Last updated
2020-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstetric Labor Complications, Staging of Placental Invasion

Brief summary

The investigators evaluated the efficacy of a staging system introduced by the American Institute of ultrasound in medicine 2015 including sonographic parameters associated with morbidly adherent placenta for antenatal prediction of placental invasion.

Detailed description

Morbidly adherent placenta (MAP) defines a spectrum of conditions, including placenta accreta, increta, and percreta, which are associated with significant maternal and fetal morbidity and mortality. Ultrasound evaluation, with grayscale, is the recommended first-line modality for diagnosing MAP. Grayscale ultrasound features suggestive of placenta accreta include the loss of myometrial interface or retroplacental clear space, reduced myometrial thickness and the presence of intraplacental lacunae. Using a staging system by antenatal ultrasound can predict placental invasion antenatally.

Interventions

DEVICEUltrasound

Pregnant women in 3rd trimester with anterior placenta previa and lower cesarean section scar. Ultrasound was done and according to parameters of the morbidly adherent placenta, a staging system was conducted.

Sponsors

Beni-Suef University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Intervention model description

Pregnant women in 3rd trimester

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Prior lower segment cesarean section * Low lying anterior placenta * Singleton pregnancy

Exclusion criteria

* Medical disorders * vasa previa

Design outcomes

Primary

MeasureTime frameDescription
Confirmation of the stage of myometrial placental invasion1 hourBy ultrasound, placental invasion in myometrium was given a stage

Secondary

MeasureTime frameDescription
Blood loss1 hourDocumentation of complications intraoperative

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026